2142
COM:HARBOURBIOMED
Harbour BioMed
- Stock
Last Close
1.22
25/11 08:08
Market Cap
1.02B
Beta: -
Volume Today
621K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
average inventory | 522K - | 522.00K 0.00% | |||||
average payables | 7.17M - | 8.64M 20.57% | 16.98M 96.52% | 24.01M 41.44% | 18.70M 22.14% | ||
average receivables | 29.72M - | ||||||
book value per share | -0.11 - | -0.20 78.65% | 2.05 1,128.36% | 0.30 85.17% | 0.13 58.24% | 0.16 24.07% | |
capex per share | -0.01 - | -0.02 170.63% | -0.00 80.01% | -0.02 465.36% | -0.03 30.35% | ||
capex to depreciation | -3.09 - | -2.89 6.44% | -0.11 96.30% | -2.09 1,847.06% | -2.29 10.02% | ||
capex to operating cash flow | 0.15 - | 0.29 95.10% | 0.02 94.02% | 0.11 563.52% | 0.18 63.13% | ||
capex to revenue | -3.28 - | -2.43 25.94% | -0.04 98.24% | -3.30 7,612.43% | -0.45 86.24% | ||
cash per share | 0.08 - | 0.04 44.33% | 2.03 4,514.49% | 0.30 85.45% | 0.24 20.30% | 0.19 21.33% | |
days of inventory on hand | 2.93K - | 0.00 100.00% | |||||
days payables outstanding | 2.83K - | 5.46K 93.02% | 6.47K 18.54% | 69.25K 970.21% | 61.85K 10.69% | 2.76K 95.54% | |
days sales outstanding | 213.38 - | ||||||
debt to assets | 0.04 - | 0.03 27.06% | 0.00 83.84% | 0.07 1,454.16% | 0.39 468.01% | 0.29 27.22% | |
debt to equity | -0.04 - | -0.01 66.02% | 0.00 138.40% | 0.09 1,726.81% | 0.98 1,022.74% | 0.54 44.58% | |
dividend yield | |||||||
earnings yield | -0.03 - | -0.06 94.05% | -1.22 1,863.21% | -0.19 84.37% | -0.52 174.22% | 0.12 123.11% | |
enterprise value | 1.02B - | 1.05B 3.12% | -111.99M 110.62% | 526.38M 570.02% | 181.79M 65.46% | 113.52M 37.56% | |
enterprise value over ebitda | -30.98 - | -16.77 45.86% | 0.38 102.30% | -4.02 1,143.55% | -1.57 60.82% | 4.26 370.65% | |
ev to operating cash flow | -30.70 - | -22.83 25.66% | 3.16 113.86% | -4.19 232.42% | -1.82 56.60% | ||
ev to sales | 689.68 - | 194.63 71.78% | -7.94 104.08% | 122.19 1,639.14% | 4.47 96.34% | 1.27 71.63% | |
free cash flow per share | -0.05 - | -0.08 55.54% | -0.20 164.72% | -0.19 6.75% | -0.16 14.97% | ||
free cash flow yield | -0.04 - | -0.05 54.64% | -0.15 170.82% | -0.19 30.57% | -0.45 133.26% | ||
graham net net | -0.14 - | -0.25 74.06% | 1.87 860.20% | 0.21 88.56% | 0.04 79.13% | 0.09 109.36% | |
graham number | 0.34 - | 0.63 86.73% | 8.83 1,304.78% | 1.14 87.13% | 0.73 35.39% | 0.33 55.53% | |
income quality | 0.96 - | 0.68 28.91% | 0.12 82.55% | 0.91 663.95% | 0.73 19.95% | ||
intangibles to total assets | 0.10 - | 0.12 16.77% | 0.02 82.98% | 0.03 49.89% | 0.04 17.00% | 0.03 4.50% | |
interest coverage | -825.31 - | -474.97 42.45% | -3.00K 530.64% | -783.17 73.85% | -62.17 92.06% | ||
interest debt per share | 0.00 - | 0.00 35.70% | 0.01 288.63% | 0.03 158.59% | 0.13 374.79% | 0.09 32.71% | |
inventory turnover | 0.12 - | 2.03M 1,633,457,558.46% | |||||
invested capital | -0.04 - | -0.01 66.02% | 0.00 138.40% | 0.09 1,726.81% | 0.98 1,022.74% | 0.54 44.58% | |
market cap | 1.08B - | 1.09B 0.58% | 243.08M 77.62% | 723.21M 197.52% | 262.57M 63.69% | 188.70M 28.13% | |
net current asset value | -101.44M - | -176.47M 73.96% | 341.57M 293.56% | 181.42M 46.89% | 69.39M 61.75% | 101.33M 46.02% | |
net debt to ebitda | 1.73 - | 0.50 71.08% | 1.22 143.81% | 1.50 23.08% | 0.70 53.44% | -2.82 503.43% | |
net income per share | -0.05 - | -0.09 95.17% | -1.69 1,818.99% | -0.19 88.84% | -0.19 0.04% | 0.03 115.94% | |
operating cash flow per share | -0.04 - | -0.06 38.71% | -0.20 234.51% | -0.17 14.79% | -0.14 20.10% | ||
payables turnover | 0.13 - | 0.07 48.19% | 0.06 15.64% | 0.01 90.66% | 0.01 11.97% | 0.13 2,143.50% | |
receivables turnover | 1.71 - | ||||||
research and ddevelopement to revenue | 21.33 - | 9.13 57.19% | 3.92 57.11% | 24.86 534.86% | 3.32 86.63% | 0.50 84.85% | |
return on tangible assets | -0.46 - | -1.10 138.99% | -0.78 29.29% | -0.50 35.33% | -0.61 21.75% | 0.10 116.84% | |
revenue per share | 0.00 - | 0.01 265.41% | 0.08 1,037.07% | 0.01 92.67% | 0.06 847.61% | 0.12 111.30% | |
roe | 0.40 - | 0.44 9.25% | -0.82 286.61% | -0.62 24.76% | -1.48 139.38% | 0.19 112.85% | |
roic | 0.47 - | 0.45 3.36% | -0.81 280.56% | -0.55 32.18% | -0.66 20.36% | 0.12 117.70% | |
sales general and administrative to revenue | 2.30 - | 0.81 64.90% | 3.28 306.19% | 2.40 26.97% | 0.25 89.66% | 0.22 12.13% | |
shareholders equity per share | -0.11 - | -0.20 78.65% | 2.05 1,128.36% | 0.30 85.17% | 0.13 58.24% | 0.16 24.07% | |
stock based compensation to revenue | 2.61 - | 1.89 27.56% | 0.14 92.52% | 0.04 68.93% | |||
tangible asset value | -94.30M - | -161.64M 71.41% | 353.21M 318.52% | 214.42M 39.29% | 84.33M 60.67% | 111.95M 32.75% | |
tangible book value per share | -0.12 - | -0.21 71.41% | 2.01 1,054.45% | 0.29 85.43% | 0.12 60.51% | 0.15 27.42% | |
working capital | 58.55M - | 28.57M 51.21% | 343.74M 1,103.29% | 199.81M 41.87% | 133.97M 32.95% | 146.05M 9.02% |
All numbers in HKD (except ratios and percentages)